Centiva Capital’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Centiva Capital’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,540	Closed	-$108K	–	2180
2023 Q1	$108K	Hold	10,540	–	–	﹤0.01%	1338
2022 Q4	$106K	Hold	10,540	–	–	﹤0.01%	1181
2022 Q3	$104K	Sell	10,540 -300	-3%	-$2.94K	﹤0.01%	1290
2022 Q2	$106K	Buy	+10,840	New	+$106K	﹤0.01%	1419

Centiva Capital's ORIA Position: Q2 2023 in Review

Centiva Capital sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 10,540 shares — an estimated $108K sold.

Centiva Capital first reported a position in ORIA in Q2 2022 and held it in 4 quarters. The position peaked at $108K in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Centiva Capital reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Centiva Capital sold 10,540 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $108K.
Centiva Capital first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q2 2022 and held it in 4 quarters.
Centiva Capital's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $108K in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Centiva Capital's 13F filing for Q2 2023, filed 14 Aug 2023.